Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
42 /100
MEDIUM RISK
Score updated Aug 28, 2026

VTVT — vTv Therapeutics Inc. Dilution Risk Tracker

Track VTVT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VTVT — Get alerts when the score changes →

As of August 28, 2026, vTv Therapeutics Inc. (VTVT) has a DilutionWatch DilutionScore of 42/100, rated MEDIUM dilution risk. vTv Therapeutics Inc. has a market capitalization of $131.35M, 3.94M shares outstanding, 35 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
40
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for VTVT.
🔔 Track VTVT — Get forecast alerts →

Market Data

Market Cap$131.35M
Shares Outstanding3.94M
Float2.14M
Cash$86.64M
Debt$2.37M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 24.9% shares (2026Q1 vs prior)
35 institutional holders · 1.60M shares
#1 SAMSARA BIOCAPITAL, LLC 298.5K shares
#2 FMR LLC 260.4K shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 217.8K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest165.8K
Days to Cover1.5
% of Float7.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2023-12-31
xbrl XBRL CONVERTIBLE 2018-12-31
4 INSIDER TRANSACTION 2026-02-18
4 INSIDER TRANSACTION 2026-02-18
Full SEC filing analysis available with free account

Recent News

No recent news

Factual VTVT Dilution Snapshot

vTv Therapeutics Inc. (VTVT) has a DilutionScore of 42/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track VTVT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VTVT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for VTVT
VTVT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.